Literature DB >> 9014857

Properties of HPV-positive and HPV-negative anal carcinomas.

G R Williams1, Q L Lu, S B Love, I C Talbot, J M Northover.   

Abstract

Evidence of human papillomavirus (HPV) can be found in up to 85 per cent of anal carcinomas. In the vulva, a discrete subset of HPV-positive carcinomas which show koilocytic morphology and distinct clinical features has recently been identified (warty carcinoma). The morphological and prognostic features of HPV-positive and HPV-negative anal carcinomas were compared in this study of the tumour distribution of HPV DNA. Vulval and anal neoplasia are similar in many ways and we have also looked to see if their similarity extends to 'warty' morphology in relation to HPV status. Thirty-five resection specimens of anal carcinoma were examined with biotin-labelled probes for HPV 6, 11, 16, and 18 DNA, using a non-isotopic in situ hybridization (ISH) technique. No tumour was found to contain HPV 6, 11, or 18. Twenty-four (72 per cent) showed positivity for HPV 16 DNA. Staining was homogeneous and independent of local squamous, basaloid, or ductal differentiation. The majority of tumours showed staining suggestive of episomal, non-productive HPV infection. HPV-positive tumours were more likely to occur in the anal canal than perianally and to show a mixed squamous and basaloid appearance. No difference between the two groups was found in patient age, presence of adjacent dysplasia, ductal differentiation, or prognosis. There was no correlation between condylomatous tumour morphology and HPV 16 DNA positivity; thus, a subset equivalent to vulval warty carcinoma could not be identified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014857     DOI: 10.1002/(SICI)1096-9896(199612)180:4<378::AID-PATH697>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

Review 1.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

2.  Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Authors:  Madhur K Garg; Fengmin Zhao; Joseph A Sparano; Joel Palefsky; Richard Whittington; Edith P Mitchell; Mary F Mulcahy; Karin I Armstrong; Nassim H Nabbout; Shalom Kalnicki; Bassel F El-Rayes; Adedayo A Onitilo; Daniel J Moriarty; Thomas J Fitzgerald; Al B Benson
Journal:  J Clin Oncol       Date:  2017-01-09       Impact factor: 44.544

3.  Epidermoid carcinoma of the anal canal.

Authors:  Bruce W Robb; Matthew G Mutch
Journal:  Clin Colon Rectal Surg       Date:  2006-05

Review 4.  Anorectal Cancer: Critical Anatomic and Staging Distinctions That Affect Use of Radiation Therapy.

Authors:  Shanna A Matalon; Harvey J Mamon; Charles S Fuchs; Leona A Doyle; Sree Harsha Tirumani; Nikhil H Ramaiya; Michael H Rosenthal
Journal:  Radiographics       Date:  2015 Nov-Dec       Impact factor: 5.333

5.  Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.

Authors:  Joseph A Sparano; Jeannette Y Lee; Joel Palefsky; David H Henry; William Wachsman; Lakshmi Rajdev; David Aboulafia; Lee Ratner; Thomas J Fitzgerald; Lisa Kachnic; Ronald Mitsuyasu
Journal:  J Clin Oncol       Date:  2016-12-12       Impact factor: 44.544

6.  Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal.

Authors:  Juan Lucas Poggio
Journal:  Clin Colon Rectal Surg       Date:  2011-09

Review 7.  Background and Current Treatment of Squamous Cell Carcinoma of the Anus.

Authors:  Rob Glynne-Jones; Waqar Saleem; Mark Harrison; Suzy Mawdsley; Marcia Hall
Journal:  Oncol Ther       Date:  2016-08-01

8.  Anal cytological abnormalities and epidemiological correlates among men who have sex with men at risk for HIV-1 infection.

Authors:  Maria Gabriella Donà; Maria Benevolo; Amina Vocaturo; Guido Palamara; Alessandra Latini; Amalia Giglio; Domenico Moretto; Francesca Rollo; Giampaolo Impara; Fabrizio Ensoli; Fulvia Pimpinelli; Aldo Di Carlo; Massimo Giuliani
Journal:  BMC Cancer       Date:  2012-10-16       Impact factor: 4.430

Review 9.  HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues.

Authors:  Margaret A Stanley; David M Winder; Jane C Sterling; Peter K C Goon
Journal:  BMC Cancer       Date:  2012-09-08       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.